These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
103 related articles for article (PubMed ID: 17920554)
1. A spectrophotometric assay for histone deacetylase 8. Fatkins DG; Zheng W Anal Biochem; 2008 Jan; 372(1):82-8. PubMed ID: 17920554 [TBL] [Abstract][Full Text] [Related]
2. Kinetics and comparative reactivity of human class I and class IIb histone deacetylases. Schultz BE; Misialek S; Wu J; Tang J; Conn MT; Tahilramani R; Wong L Biochemistry; 2004 Aug; 43(34):11083-91. PubMed ID: 15323567 [TBL] [Abstract][Full Text] [Related]
3. Nepsilon-thioacetyl-lysine: a multi-facet functional probe for enzymatic protein lysine Nepsilon-deacetylation. Fatkins DG; Monnot AD; Zheng W Bioorg Med Chem Lett; 2006 Jul; 16(14):3651-6. PubMed ID: 16697640 [TBL] [Abstract][Full Text] [Related]
4. A homogeneous cellular histone deacetylase assay suitable for compound profiling and robotic screening. Ciossek T; Julius H; Wieland H; Maier T; Beckers T Anal Biochem; 2008 Jan; 372(1):72-81. PubMed ID: 17868634 [TBL] [Abstract][Full Text] [Related]
5. Cloning and characterization of a novel human histone deacetylase, HDAC8. Buggy JJ; Sideris ML; Mak P; Lorimer DD; McIntosh B; Clark JM Biochem J; 2000 Aug; 350 Pt 1(Pt 1):199-205. PubMed ID: 10926844 [TBL] [Abstract][Full Text] [Related]
6. Development of a scintillation proximity assay for histone deacetylase using a biotinylated peptide derived from histone-H4. Nare B; Allocco JJ; Kuningas R; Galuska S; Myers RW; Bednarek MA; Schmatz DM Anal Biochem; 1999 Feb; 267(2):390-6. PubMed ID: 10036146 [TBL] [Abstract][Full Text] [Related]
7. Development and optimization of a binding assay for histone deacetylase 4 using surface plasmon resonance. Mattu M; Di Giovine P; Steinkuhler C; De Francesco R; Altamura S; Cecchetti O; Carfì A; Barbato G Anal Biochem; 2008 Jun; 377(2):267-9. PubMed ID: 18381195 [TBL] [Abstract][Full Text] [Related]
8. A miniaturized readout strategy for endogenous histone deacetylase activity. Jost JO; Hanswillemenke A; Schwarzer D Mol Biosyst; 2015 Jul; 11(7):1820-3. PubMed ID: 26009008 [TBL] [Abstract][Full Text] [Related]
9. A mechanism-based inactivator for histone demethylase LSD1. Culhane JC; Szewczuk LM; Liu X; Da G; Marmorstein R; Cole PA J Am Chem Soc; 2006 Apr; 128(14):4536-7. PubMed ID: 16594666 [TBL] [Abstract][Full Text] [Related]
10. Hydroxychloroquine, chloroquine, and all-trans retinoic acid regulate growth, survival, and histone acetylation in breast cancer cells. Rahim R; Strobl JS Anticancer Drugs; 2009 Sep; 20(8):736-45. PubMed ID: 19584707 [TBL] [Abstract][Full Text] [Related]
11. Statins increase p21 through inhibition of histone deacetylase activity and release of promoter-associated HDAC1/2. Lin YC; Lin JH; Chou CW; Chang YF; Yeh SH; Chen CC Cancer Res; 2008 Apr; 68(7):2375-83. PubMed ID: 18381445 [TBL] [Abstract][Full Text] [Related]
12. Histone deacetylase 8 in neuroblastoma tumorigenesis. Oehme I; Deubzer HE; Wegener D; Pickert D; Linke JP; Hero B; Kopp-Schneider A; Westermann F; Ulrich SM; von Deimling A; Fischer M; Witt O Clin Cancer Res; 2009 Jan; 15(1):91-9. PubMed ID: 19118036 [TBL] [Abstract][Full Text] [Related]
13. Fluorescence assay of SIRT protein deacetylases using an acetylated peptide substrate and a secondary trypsin reaction. Marcotte PA; Richardson PL; Guo J; Barrett LW; Xu N; Gunasekera A; Glaser KB Anal Biochem; 2004 Sep; 332(1):90-9. PubMed ID: 15301953 [TBL] [Abstract][Full Text] [Related]
14. Molecular modifications on carboxylic acid derivatives as potent histone deacetylase inhibitors: Activity and docking studies. Bora-Tatar G; Dayangaç-Erden D; Demir AS; Dalkara S; Yelekçi K; Erdem-Yurter H Bioorg Med Chem; 2009 Jul; 17(14):5219-28. PubMed ID: 19520580 [TBL] [Abstract][Full Text] [Related]
15. Modulation of the cyclin-dependent kinase inhibitor p21(WAF1/Cip1) gene by Zac1 through the antagonistic regulators p53 and histone deacetylase 1 in HeLa Cells. Liu PY; Chan JY; Lin HC; Wang SL; Liu ST; Ho CL; Chang LC; Huang SM Mol Cancer Res; 2008 Jul; 6(7):1204-14. PubMed ID: 18644983 [TBL] [Abstract][Full Text] [Related]
16. Histone deacetylases as transducers and targets of nuclear signaling. Walkinshaw DR; Tahmasebi S; Bertos NR; Yang XJ J Cell Biochem; 2008 Aug; 104(5):1541-52. PubMed ID: 18425769 [TBL] [Abstract][Full Text] [Related]
17. N(epsilon)-methanesulfonyl-lysine as a non-hydrolyzable functional surrogate for N(epsilon)-acetyl-lysine. Jamonnak N; Fatkins DG; Wei L; Zheng W Org Biomol Chem; 2007 Mar; 5(6):892-6. PubMed ID: 17340003 [TBL] [Abstract][Full Text] [Related]
18. Optimization of a series of potent and selective ketone histone deacetylase inhibitors. Pescatore G; Kinzel O; Attenni B; Cecchetti O; Fiore F; Fonsi M; Rowley M; Schultz-Fademrecht C; Serafini S; Steinkühler C; Jones P Bioorg Med Chem Lett; 2008 Oct; 18(20):5528-32. PubMed ID: 18809328 [TBL] [Abstract][Full Text] [Related]
19. HDAC6, at the crossroads between cytoskeleton and cell signaling by acetylation and ubiquitination. Boyault C; Sadoul K; Pabion M; Khochbin S Oncogene; 2007 Aug; 26(37):5468-76. PubMed ID: 17694087 [TBL] [Abstract][Full Text] [Related]
20. Reticulon RTN1-C(CT) peptide: a potential nuclease and inhibitor of histone deacetylase enzymes. Nepravishta R; Bellomaria A; Polizio F; Paci M; Melino S Biochemistry; 2010 Jan; 49(2):252-8. PubMed ID: 20000484 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]